Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT

Yiftach Roth, Noam Barnea-Ygael, Lior Carmi, Eric A. Storch, Aron Tendler, Abraham Zangen

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء

ملخص

OCD is a chronic and disabling disease with a lifetime prevalence of 2%-3%. About 40–60% of these patients do not adequately respond to pharmacotherapy and CBT. Deep transcranial magnetic stimulation (dTMS) was shown to be safe and effective as a treatment alternative for OCD and recently received regulatory approvals. Yet it is unclear whether patients who failed numerous medications and/or CBT can still benefit from dTMS. Here, we analyzed recent data from a double-blind multicenter dTMS study and found efficacy of this novel treatment even in OCD patient cohorts who previously failed to respond to multiple medications and CBT.

اللغة الأصليةإنجليزيّة أمريكيّة
رقم المقال113179
دوريةPsychiatry Research
مستوى الصوت290
المعرِّفات الرقمية للأشياء
حالة النشرنُشِر - 1 أغسطس 2020

All Science Journal Classification (ASJC) codes

  • !!Psychiatry and Mental health
  • !!Biological Psychiatry

بصمة

أدرس بدقة موضوعات البحث “Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا